Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
CTNM4 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in CONTINEUM THERAPEUTICS INC
Yes. Balyasny Asset Management holds 1,522,793 shares of CTNM (Contineum Therapeutics), worth $25M, as of its Q2 2026 13F filing. It reduced the position by 162,842 shares (-9.7%) from Q1 2026. Balyasny Asset Management has held CTNM since Q3 2025, across 4 quarterly 13F filings.
Current Value
$25M
Current Shares
1.5M
Total Value Change
+$13.8M
Total Shares Change
+571,473
Quarter-by-Quarter History
Other major holders of CTNM: Jupiter Topco LLC, Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN TEMPLETON INC